Ölgerðin Egill Skallagrímsson hf.: Niðurstöður aðalfundar 2024
May 23, 2024 14:35 ET
|
Ölgerðin Egill Skallagrimsson
Aðalfundur Ölgerðarinnar var haldinn 23. maí 2024 í höfuðstöðvum félagsins að Grjóthálsi 7-11, 110 Reykjavík. Meðfylgjandi eru helstu niðurstöður fundarins.
Viðhengi
...
Earlyworks Co., Ltd., a blockchain technology provider, forms business alliance with Relic, a business co-creation company
May 21, 2024 08:30 ET
|
EARLYWORKS CO., LTD.
TOKYO, May 21, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”) (Head office: Taito-ku, Tokyo; CEO: Satoshi Kobayashi), a blockchain solution provider...
Ölgerðin Egill Skallagrímsson hf.: Framboð til stjórnar
May 18, 2024 12:19 ET
|
Ölgerðin Egill Skallagrimsson
Aðalfundur Ölgerðarinnar Egill Skallagrímsson hf. verður haldinn fimmtudaginn 23. maí 2024, kl. 16:00, í höfuðstöðvum félagsins að Grjóthálsi 7-11 í Reykjavík. Framboðsfrestur til stjórnar rann...
H World Group Limited Reports First Quarter of 2024 Unaudited Financial Results
May 17, 2024 06:15 ET
|
H World Group Limited
A total of 9,817 hotels or 955,657 hotel rooms in operation as of March 31, 2024.Hotel turnover1 increased 21.1% year-over-year to RMB19.7 billion in the first quarter of 2024. Excluding Steigenberger...
Multitude Group publishes restated interim results for 2023 due to prior period adjustments and changes in presentation
May 15, 2024 02:00 ET
|
Multitude SE
Multitude Group publishes restated interim results for 2023 due to prior period adjustments and changes in presentation Helsinki, 15 May 2024 – Multitude SE, a listed European FinTech company,...
Element Reports Record First Quarter Results
May 14, 2024 17:01 ET
|
Element Fleet Management
Amounts in US$ unless otherwise noted Record quarterly net revenue of US$262.5 million driving record adjusted EPS of US$0.27 and adjusted free cash flow per share of US$0.35Solid net revenue growth...
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
May 14, 2024 16:05 ET
|
Metagenomi, Inc.
Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational development program in Hemophilia A; development candidate nomination anticipated in mid-year 2024;...
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024 08:00 ET
|
Prime Medicine, Inc.
-- Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2 clinical trial expected in 2025 -- --...
Axovia Therapeutics Announces Presentation of Preclinical Data Supporting Lead Program AXV-101 for Treatment of Blindness Associated with BBS1 Mutations at ASGCT
May 10, 2024 07:00 ET
|
Axovia Therapeutics LTD
- Data show that AXV-101 halts photoreceptor and outer nuclear retinal layer (ONL) degeneration in a dose-dependent manner - - Company to initiate clinical studies in 1H 2025 to treat blindness and...
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
May 10, 2024 06:50 ET
|
ANI Pharmaceuticals, Inc.
Generated record quarterly net revenues of $137.4 million, representing year-over-year growth of 28.7%, net income to common shareholders of $17.8 million, and GAAP diluted earnings per share of...